Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperparathyroidism-Chronic Kidney Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Large-scale testing (Phase 3)Study completedNCT00345839
What this trial is testing

E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 3,883
Early research (Phase 1)Study completedNCT00888069
What this trial is testing

Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 28
Testing effectiveness (Phase 2)Looking for participantsNCT06976177
What this trial is testing

Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 310
Testing effectiveness (Phase 2)Study completedNCT02977117
What this trial is testing

The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis

Who this might be right for
Endstage Renal Disease
Iain Bressendorff 59
Large-scale testing (Phase 3)Ended earlyNCT01277510
What this trial is testing

Pediatric Chronic Kidney Disease Safety and Efficacy

Who this might be right for
Chronic Kidney DiseaseHyperparathyroidismHyperparathyroidism, Secondary+2 more
Amgen 43
Post-approval studies (Phase 4)UnknownNCT03023748
What this trial is testing

Intravenous Paricalcitol in Chronic Hemodialysis Patients

Who this might be right for
Endstage Renal DiseaseSecondary Hyperparathyroidism
The University of Hong Kong 30
Large-scale testing (Phase 3)Study completedNCT01704079
What this trial is testing

Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency

Who this might be right for
Chronic Kidney DiseaseHyperparathyroidism, SecondaryVitamin D Deficiency
OPKO IP Holdings II, Inc. 216
Post-approval studies (Phase 4)Study completedNCT00454350
What this trial is testing

Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Genzyme, a Sanofi Company 12
Not applicableEnded earlyNCT01134315
What this trial is testing

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Who this might be right for
Secondary HyperparathyroidismEnd-Stage Renal Disease
AbbVie (prior sponsor, Abbott) 61
Testing effectiveness (Phase 2)Study completedNCT06747247
What this trial is testing

A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 98
Testing effectiveness (Phase 2)Study completedNCT00646932
What this trial is testing

Paricalcitol Injection Phase II Trial

Who this might be right for
Chronic Kidney Disease
Abbott 25
Large-scale testing (Phase 3)Study completedNCT01932970
What this trial is testing

Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 158
Large-scale testing (Phase 3)Study completedNCT00094484
What this trial is testing

Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis

Who this might be right for
Kidney DiseaseChronic Kidney Disease
Amgen 400
Testing effectiveness (Phase 2)Study completedNCT00113958
What this trial is testing

Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels

Who this might be right for
End Stage Renal Disease
Amgen
Testing effectiveness (Phase 2)Study completedNCT06236295
What this trial is testing

Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shanghai Hengrui Pharmaceutical Co., Ltd. 303
Large-scale testing (Phase 3)UnknownNCT00752401
What this trial is testing

Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationVitamin D DeficiencyRenal Osteodystrophy
Medical University of Vienna 200
Large-scale testing (Phase 3)Ended earlyNCT04064827
What this trial is testing

Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)
AbbVie 2